| Siddarth Rathi, MD, MBA | |
|
148 13th St Sw, Largo, FL 33770 | |
| (727) 581-8706 | |
| (727) 588-2447 |
| Full Name | Siddarth Rathi |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 148 13th St Sw, Largo, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063770469 | NPI | - | NPPES |
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Affymetrix and BioDiscovery, Inc. today announced the launch of a new analysis software, Nexus Copy Number for Affymetrix, which is specifically for data generated by Affymetrix' genetic analysis platforms in cancer research, including CytoScan Cytogenetics Suite and OncoScan FFPE Assay Kit.
Monell Center scientist Kai Zhao, PhD, is principal investigator on a $1.5M 4-year grant from the National Institute on Deafness and Other Communication Disorders, part of the National Institutes of Health, to further develop clinical methodology that can predict the path of air flow through a person's nasal passages.
They say time heals all wounds, and new research from the University of California, Berkeley, indicates that time spent in dream sleep can help. UC Berkeley researchers have found that during the dream phase of sleep, also known as REM sleep, our stress chemistry shuts down and the brain processes emotional experiences and takes the painful edge off difficult memories.
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
A new study revealed today at The International Liver Congress 2015 shows that sofosbuvir (SOF)-based regimens are effective and well tolerated in hepatitis C and HIV co-infected, cirrhotic patients. Sustained virologic response at 4 weeks (SVR4) was observed in 98% of patients and in 95% at 12 weeks (SVR12).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Siddarth Rathi, MD, MBA 148 13th St Sw, Largo, FL 33770-3127 Ph: (727) 581-8706 | Siddarth Rathi, MD, MBA 148 13th St Sw, Largo, FL 33770 Ph: (727) 581-8706 |
News Archive
Affymetrix and BioDiscovery, Inc. today announced the launch of a new analysis software, Nexus Copy Number for Affymetrix, which is specifically for data generated by Affymetrix' genetic analysis platforms in cancer research, including CytoScan Cytogenetics Suite and OncoScan FFPE Assay Kit.
Monell Center scientist Kai Zhao, PhD, is principal investigator on a $1.5M 4-year grant from the National Institute on Deafness and Other Communication Disorders, part of the National Institutes of Health, to further develop clinical methodology that can predict the path of air flow through a person's nasal passages.
They say time heals all wounds, and new research from the University of California, Berkeley, indicates that time spent in dream sleep can help. UC Berkeley researchers have found that during the dream phase of sleep, also known as REM sleep, our stress chemistry shuts down and the brain processes emotional experiences and takes the painful edge off difficult memories.
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
A new study revealed today at The International Liver Congress 2015 shows that sofosbuvir (SOF)-based regimens are effective and well tolerated in hepatitis C and HIV co-infected, cirrhotic patients. Sustained virologic response at 4 weeks (SVR4) was observed in 98% of patients and in 95% at 12 weeks (SVR12).
› Verified 1 days ago
Philip Lee Shettle, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 13113 66th St, Largo, FL 33773 Phone: 727-674-2500 Fax: 727-674-2550 | |
Stacia H Goldey, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 148 13th St Sw, Largo, FL 33770 Phone: 727-581-8706 Fax: 727-588-2447 | |
Dr. Bradley Philip Oneill, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 148 13th St Sw, Largo, FL 33770 Phone: 727-581-8706 Fax: 727-588-2447 | |
Dr. Winston T Cope, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 148 13th St Sw, Largo, FL 33770 Phone: 727-642-0301 | |
Dr. Frank Seidl, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2770 E Bay Dr, Largo, FL 33771 Phone: 727-530-1425 | |
Robert Davis, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 148 13th St Sw, Largo, FL 33770 Phone: 727-581-8706 |